GlobeNewswire: Enovis Corporation Contains the last 10 of 172 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T14:09:52ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2024/03/28/2853843/0/en/Enovis-to-Participate-in-the-23rd-Annual-Needham-Virtual-Healthcare-Conference.html?f=22&fvtc=4&fvtv=26598Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference2024-03-28T11:00:00Z<![CDATA[Wilmington, DE, March 28, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV) ("Enovis" or the "Company"), an innovation-driven, medical technology growth company, today announced that management will participate in the upcoming 23rd Annual Needham Virtual Healthcare Conference. The presentation is scheduled to begin at 3:45 p.m. Eastern Time on Tuesday, April 9, 2024.]]>https://www.globenewswire.com/news-release/2024/02/22/2833461/0/en/Enovis-Announces-Fourth-Quarter-and-Full-Year-2023-Results.html?f=22&fvtc=4&fvtv=26598Enovis Announces Fourth Quarter and Full Year 2023 Results2024-02-22T11:00:00Z<![CDATA[Wilmington, DE, Feb. 22, 2024 (GLOBE NEWSWIRE) -- —Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2023. The Company will host an investor conference call and live webcast to discuss these results today at 8:30 am ET.]]>https://www.globenewswire.com/news-release/2024/02/12/2827698/0/en/Enovis-to-Highlight-Latest-Technologies-Across-the-Orthopedic-Care-Continuum-at-2024-AAOS-Annual-Meeting.html?f=22&fvtc=4&fvtv=26598Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting2024-02-12T16:30:00Z<![CDATA[WILMINGTON, DE, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology company, will showcase its latest technologies across the orthopedic care continuum at the American Academy of Orthopedic Surgeons Annual Meeting 2024. In addition, the Company will present itself as a newly integrated company following the acquisition of orthopedic leader LimaCorporate S.p.A (“Lima”).]]>https://www.globenewswire.com/news-release/2024/02/07/2825573/0/en/Enovis-to-Present-at-the-Canaccord-Genuity-Musculoskeletal-Conference-on-Monday-February-12-2024.html?f=22&fvtc=4&fvtv=26598Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 20242024-02-07T21:15:00Z<![CDATA[Wilmington, DE, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that Brady Shirley, President and COO, Ben Berry, CFO, and Louis Vogt, Group President Recon will present at the Canaccord Genuity Musculoskeletal Conference. The presentation is scheduled to begin at 5:30pm p.m. ET (2:30 p.m. PT) on Monday, February 12, 2024.]]>https://www.globenewswire.com/news-release/2024/01/29/2818863/0/en/Enovis-Showcases-New-Foot-Ankle-Offerings-at-the-ACFAS-Annual-Meeting.html?f=22&fvtc=4&fvtv=26598Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting 2024-01-29T13:00:00Z<![CDATA[New solutions in Percutaneous and Open Bunion procedures, External Fixation, and STAR® Ankle will be featured as part of the company’s growing evidence-based, innovative portfolio. New solutions in Percutaneous and Open Bunion procedures, External Fixation, and STAR® Ankle will be featured as part of the company’s growing evidence-based, innovative portfolio.]]>Just some of the products Enovis Foot & Ankle will feature at the ACFAS Annual Meeting, February 1-4, 2024.Enovis at ACFAS 2024https://www.globenewswire.com/news-release/2024/01/26/2817774/0/en/Enovis-to-Host-Fourth-Quarter-and-Full-Year-2023-Conference-Call-on-February-22nd.html?f=22&fvtc=4&fvtv=26598Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd2024-01-26T11:00:00Z<![CDATA[Wilmington, DE, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its fourth quarter and full year 2023 financial results on Thursday, February 22, 2024 at 8:30AM ET and issue an earnings press release earlier that morning. A presentation related to the call will be available on www.enovis.com in the “Investors” section.]]>https://www.globenewswire.com/news-release/2024/01/25/2816757/0/en/Enovis-Introduces-the-DonJoy-ROAM-OA-Knee-Brace.html?f=22&fvtc=4&fvtv=26598Enovis Introduces the DonJoy ROAM™ OA Knee Brace2024-01-25T13:30:00Z<![CDATA[The newest innovation in unloader braces is comfortable, easy to use and effective. The newest innovation in unloader braces is comfortable, easy to use and effective.]]>The Enovis DonJoy ROAM™ OA Knee Brace.Enovis DonJoy ROAM™ OA Knee Bracehttps://www.globenewswire.com/news-release/2024/01/03/2803545/0/zh-hans/Enovis-%E5%AE%8C%E6%88%90%E5%AF%B9-LimaCorporate-S-p-A-%E7%9A%84%E6%94%B6%E8%B4%AD.html?f=22&fvtc=4&fvtv=26598Enovis 完成对 LimaCorporate S.p.A 的收购2024-01-03T18:26:11Z<![CDATA[威尔明顿,特拉华州, Jan. 04, 2024 (GLOBE NEWSWIRE) -- 创新驱动的医疗技术成长型公司 Enovis™ Corporation(NYSE: ENOV,简称“Enovis”或“公司”)今日宣布完成对 LimaCorporate S.p.A (简称“Lima”)的收购。Lima 是私人控股的全球骨科领导者,专注于通过创新的植入物解决方案组合恢复运动。]]>https://www.globenewswire.com/news-release/2024/01/03/2803545/0/zh-hant/Enovis-%E5%AE%8C%E6%88%90%E5%B0%8D-LimaCorporate-S-p-A-%E7%9A%84%E6%94%B6%E8%B3%BC.html?f=22&fvtc=4&fvtv=26598Enovis 完成對 LimaCorporate S.p.A 的收購2024-01-03T18:26:11Z<![CDATA[威爾明頓,特拉華州, Jan. 04, 2024 (GLOBE NEWSWIRE) -- 創新驅動的醫療技術成長型公司 Enovis™ Corporation (NYSE: ENOV,以下簡稱「Enovis」或「公司」)今日宣布已完成對 LimaCorporate S.p.A (以下簡稱「Lima」)的收購。Lima 是一家私人控股的全球骨科領先企業,專注於透過創新的植入解決方案組合恢復運動功能。]]>https://www.globenewswire.com/news-release/2024/01/03/2803545/0/fr/Enovis-finalise-l-acquisition-de-LimaCorporate-S-p-A.html?f=22&fvtc=4&fvtv=26598Enovis finalise l’acquisition de LimaCorporate S.p.A.2024-01-03T18:26:11Z<![CDATA[WILMINGTON, Delaware, 03 janv. 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE : ENOV, « Enovis » ou la « société ») une entreprise en pleine croissance dans le domaine des technologies médicales axée sur l’innovation a annoncé, ce jour, avoir finalisé l’acquisition de LimaCorporate S.p.A. (« Lima »), leader mondial privé dans le domaine de l’orthopédie qui s’efforce de rétablir l’émotion du mouvement grâce à une gamme innovante de solutions implantaires.]]>